Marketing and Sales Agency Stream Creative Featured in Google's Annual Economic Impact Report The Milwaukee-based agency is recognized for helping businesses grow through creative strategy, digital and AI tools, and a people-first approach. GlobeNewswire May 28, 2025 Milwaukee, WIS, May 28, 2025 (GLOBE NEWSWIRE) — Marketing and sales agency Stream Creative of Milwaukee, Wisconsin announced […]

Verve Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire May 28, 2025 BOSTON , May 28, 2025 (GLOBE NEWSWIRE) — Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that management will participate in fireside chats during the following investor conferences: Jefferies Global Healthcare Conference on Wednesday,

Olema Oncology Announces Palazestrant Dose Selection and Trial-in-Progress Poster at ASCO 2025 Annual Meeting GlobeNewswire May 28, 2025 90 mg once-daily palazestrant dose selected for Part 2 of the Phase 3 OPERA-01 monotherapy trial and for the Phase 3 OPERA-02 combination trial with ribociclib OPERA-01 trial-in-progress poster to be presented on Monday, June 2 between

OTC Markets Group Welcomes Magna Mining Inc. to OTCQX GlobeNewswire May 28, 2025 NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced that Magna Mining Inc. (TSX-V: NICU; OTCQX: MGMNF), a company engaged in the acquisition, production,

Agios to Present at Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025 GlobeNewswire May 28, 2025 CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced that its management team is scheduled

Balchem Corporation to Present at the Wells Fargo Industrials and Materials Conference on June 11, 2025 GlobeNewswire May 28, 2025 MONTVALE, N.J., May 28, 2025 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the Wells Fargo Industrials and Materials Conference on

Major Drilling to Release Results for its Fourth Quarter and Fiscal 2025 on June 11, 2025 Management to Host Webcast/Conference Call on Thursday, June 12, 2025 at 8:00am EDT GlobeNewswire May 28, 2025 MONCTON, New Brunswick, May 28, 2025 (GLOBE NEWSWIRE) — Major Drilling Group International Inc. (TSX: MDI) (the “Company”) will release its fourth

TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference GlobeNewswire May 28, 2025 WALTHAM, Mass., May 28, 2025 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer, today announced that

Avacta Therapeutics Announces Appointments of Industry Veterans to Board of Directors GlobeNewswire May 28, 2025 LONDON and PHILADELPHIA, May 28, 2025 (GLOBE NEWSWIRE) — Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads directly to the tumor, today announces the appointments of David Bryant and

Axsome Therapeutics Presents Data from Three of Its Innovative Neuroscience Programs at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting GlobeNewswire May 28, 2025 NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders,